Peramivir: BCRX completed enrollment of 1,300 patients in an international Phase III trial of oral Peramivir to treat acute influenza A and B infection. The tri

BioCryst Pharmaceuticals Inc. (BCRX), Birmingham, Ala. Product: Peramivir ( RWJ-270201, BCX-1812) Business: Infectious diseases Therapeutic category: Viral infection Target: Neuraminidase Descripti...